Healthcare of Ontario Pension Plan (HOOPP) Trust Fund’s Oaktree Acquisition Corp III Life Sciences Warrant OACCW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$255K Hold
340,000
﹤0.01% 1293
2025
Q4
$241K Hold
340,000
﹤0.01% 1256
2025
Q3
$296K Hold
340,000
﹤0.01% 1054
2025
Q2
$289K Hold
340,000
﹤0.01% 986
2025
Q1
$255K Buy
+340,000
New +$258K ﹤0.01% 898

Other funds holding OACCW

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund's OACCW Position: Q1 2026 in Review

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund held its Oaktree Acquisition Corp III Life Sciences Warrant (OACCW) position steady in Q1 2026 at 340,000 shares worth $255K. The position accounts for ﹤0.01% of the portfolio, ranked #1293.

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund first reported a position in OACCW in Q1 2025 and has held it in 5 quarters since. The position peaked at $296K in Q3 2025. 26 funds tracked by Wall St. Rank hold OACCW as of Q1 2026.

  • Healthcare of Ontario Pension Plan (HOOPP) Trust Fund held 340,000 shares of Oaktree Acquisition Corp III Life Sciences Warrant worth $255K as of Q1 2026.
  • Healthcare of Ontario Pension Plan (HOOPP) Trust Fund left its Oaktree Acquisition Corp III Life Sciences Warrant share count unchanged in Q1 2026.
  • Oaktree Acquisition Corp III Life Sciences Warrant made up ﹤0.01% of Healthcare of Ontario Pension Plan (HOOPP) Trust Fund's portfolio in Q1 2026, its #1293 holding.
  • Healthcare of Ontario Pension Plan (HOOPP) Trust Fund first reported a position in Oaktree Acquisition Corp III Life Sciences Warrant in Q1 2025 and has held it in 5 quarters since.
  • Healthcare of Ontario Pension Plan (HOOPP) Trust Fund's Oaktree Acquisition Corp III Life Sciences Warrant position peaked at $296K in Q3 2025.
  • 26 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences Warrant as of Q1 2026.

Based on Healthcare of Ontario Pension Plan (HOOPP) Trust Fund's 13F filing for Q1 2026, filed 14 May 2026.